Skip to main content
Amphastar Pharmaceuticals, Inc. logo

Amphastar Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · AMPH ISIN · US03209R1032 LEI · 54930055TH0ZLSAQMJ38 US Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2017-03-21 Director's Dealing
Country US United States of America
Listing US AMPH

About Amphastar Pharmaceuticals, Inc.

https://amphastar.com/

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing technically challenging medications. Its portfolio includes generic and proprietary injectable, intranasal, and inhalation products. The company specializes in complex medications such as biologics derived from living cells, proteins, and interchangeable biosimilars. Amphastar also develops innovative drug delivery systems and proprietary technological platforms for various routes of administration.

Recent filings

Filing Released Lang Actions
4
Director's Dealing
2017-03-21 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by Amphastar Pharmaceuticals, Inc. on March 15, 2017. Form S-8 is used to register securities to be offered under employee benefit plans, such as equity incentive plans. The text includes details about the registration of additional shares under the 2015 Equity Incentive Plan, references to the Securities Act of 1933, and incorporation by reference of prior filings including the company's Annual Report on Form 10-K. There is no financial performance data or earnings information presented; rather, it is a regulatory filing related to securities registration for employee stock plans. This type of document does not fit into categories like Annual Report (10-K), Earnings Release, or Capital/Financing Update. It is a regulatory filing specific to securities registration under the Securities Act. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a proxy statement but a full registration statement filing.
2017-03-15 English
10-K
Annual Report FY 2016
2017-03-14 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The key content is Item 2.02, which states the company issued a press release announcing financial results for the quarter and fiscal year ended December 31, 2016. The document includes the press release as an exhibit but does not contain the full financial statements or detailed analysis itself. The length is only 3006 characters, indicating it is a brief announcement rather than a full earnings release. According to the rules, a short document announcing a financial results press release should be classified as a Regulatory Filing (RNS) rather than an Earnings Release (ER) or Interim Report (IR).
2017-03-13 English
SC 13G AMENDMENT NO. 2
Major Shareholding Notification
2017-02-11 English
Major Shareholding Notification 2017
Major Shareholding Notification
2017-01-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.